PSYBIO THERAP. (SUB.VT.) Aktie - Unternehmensdaten & Kurse - CA6936971044 | MoneyPeak

PSYBIO THERAP. (SUB.VT.)

Share · CA6936971044 · A2QQYS (XTSX)

No Price

n/a

Company Profile for PSYBIO THERAP. (SUB.VT.) Share

PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.

Get up to date insights from finAgent about PSYBIO THERAP. (SUB.VT.)

Company Data

Name PSYBIO THERAP. (SUB.VT.)

Company PsyBio Therapeutics Corp.

Website https://www.psybiolife.com

Primary Exchange

TSX-V

WKN A2QQYS

ISIN CA6936971044

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Evan Mike Levine

Country United States of America

Currency EUR

Employees 0,0 T

Address 4400 West Sample Road, 33073 Coconut Creek

IPO Date 2021-02-25

Ticker Symbols

Name	Symbol
TSX-V	PSYB.V

More Shares

Investors who hold PSYBIO THERAP. (SUB.VT.) also have the following shares in their portfolio:

HSBC S 16/23 Bond

Linkers Corporation Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025